What This Treatment Is

Alcohol MAT is Medication-Assisted Treatment for alcohol use disorder (AUD). Despite alcohol being the most widely used substance in this country, medication for AUD is often overlooked — many people don’t know it exists. It does, it’s FDA-approved, and it works. The American Psychiatric Association recommends medication as part of comprehensive AUD care.

FDA-Approved Medications for AUD

Three medications are FDA-approved for alcohol use disorder. Naltrexone (oral, daily) reduces heavy drinking days by blunting the reward from alcohol. Extended-release naltrexone (Vivitrol, monthly injection) has the same mechanism with once-monthly dosing. Acamprosate (oral, three times daily) reduces post-abstinence craving and dysphoria. Disulfiram (oral, daily) produces an unpleasant reaction if the patient drinks — used selectively in patients ready for full abstinence and comfortable with that consequence.

Who Alcohol MAT Is For

Alcohol MAT is a fit for adults meeting DSM-5 criteria for alcohol use disorder — from moderate to severe. It’s not only for people at the extreme end. Someone with a moderate AUD who wants to reduce heavy drinking days is a candidate for oral naltrexone. Someone with severe AUD who is entering full abstinence is a candidate for Vivitrol or acamprosate. Medication is matched to goals.

Our Care Model: Specialty-Led, Distinct Primary Tracks

Elevated Healing operates separate primary treatment tracks for Mental Health and Substance Use, each led by the appropriate clinical specialty from day one. When both are present, our teams coordinate care across tracks so the full clinical picture is addressed without collapsing treatment into a single generalized program.

This is different from a blended or generalized model. Read more on our Care Model page.

Elevated Healing’s Specialty-Led Approach

Alcohol MAT at our Woodland Hills campus is prescribed by board-certified psychiatric providers. Medication is always paired with therapy — that’s the substance of MAT, not the medication alone.

The clinical process:

  • Full psychiatric and substance use evaluation at intake, including a review of drinking history, prior treatment, and medical status (liver function, sleep, mood).
  • Medication selection based on goals: reduce heavy drinking days (oral naltrexone), extended-release compliance support (Vivitrol), post-abstinence craving reduction (acamprosate), or reactive deterrent (disulfiram).
  • Concurrent therapy: CBT, motivational enhancement therapy, and — when appropriate — EMDR for underlying trauma driving the drinking.
  • Regular follow-up: weekly early, then monthly. Progress is reviewed by measurable outcomes (drinking days, cravings, functional recovery).
  • Coordinated psychiatric care when depression, anxiety, or PTSD are also present.
Evidence base. Guidance from the American Psychiatric Association and the Substance Abuse and Mental Health Services Administration establishes naltrexone and acamprosate as evidence-based options that meaningfully reduce heavy drinking days when combined with therapy.

Access at Our Woodland Hills Campus

Our campus is at 21250 Califa St, Ste 114, Woodland Hills, CA 91367, in the West San Fernando Valley. Access is straightforward:

  • From the 101 (Ventura Freeway) — exit at De Soto Avenue or Winnetka Avenue and drive a short distance north.
  • From the 118 (Ronald Reagan Freeway) — take Winnetka or De Soto south into the West Valley.
  • Nearby communities — Warner Center, Winnetka, West Hills, Canoga Park, Tarzana, and Encino are all a short drive.
  • Telehealth — after your initial in-person assessment, most follow-up psychiatric visits can be done by video for California residents.

Parking and check-in details are provided at intake. If accessibility accommodations are needed, tell our admissions team when you call.

Program Levels That Deliver This Care

This service is delivered inside the level of care that matches your clinical need at intake. Level of care can shift over time as treatment progresses.

Partial Hospitalization (PHP)

Structured day program, five days per week, with psychiatric oversight and integrated therapy.

Learn about PHP

Intensive Outpatient (IOP)

Three-to-five sessions per week that allow work or school to continue.

Learn about IOP

Outpatient (OP)

Weekly therapy plus regular psychiatric visits — well-suited to step-down maintenance.

Learn about OP

Telehealth Follow-Up

Video visits with the psychiatric provider, available across California for eligible patients.

Learn about telehealth

Insurance, Cost, and Getting Started

Most commercial insurance plans cover alcohol mat under mental health and substance use disorder benefits, which are subject to federal parity requirements under the Mental Health Parity and Addiction Equity Act. Parity means insurers cannot impose stricter limits on behavioral health services than they apply to physical health services — a real legal protection worth knowing you have when you call.

The first step is a conversation with our admissions team. This call is free, confidential, and carries no obligation. During it, we:

  • Verify your insurance benefits within one business day.
  • Confirm what’s covered, what your copay or coinsurance will be, and whether prior authorization applies.
  • Start any required prior authorization on your behalf so you’re not stuck on hold with your insurer.
  • Schedule a clinical evaluation — usually within a few business days of your first call, sooner when the situation is time-sensitive.

If insurance doesn’t cover the service or your plan design doesn’t fit, self-pay options can be discussed. There is no charge to have this conversation. Reach us at (747) 888-3000 or use our insurance verification form.

What Progress Looks Like

Recovery through alcohol mat is not a straight line, and durable clinical outcomes rarely happen in weeks. Realistic timelines matter here more than optimistic promises. Most patients notice measurable improvement in the first month of consistent treatment — reduced cravings, more stable mood, better sleep, easier engagement with therapy. Substantive behavioral change typically takes root over three to six months.

Progress is reviewed at every clinical visit. We measure it in specifics: frequency of the target behavior, functional recovery in work and relationships, sleep quality, and — where medications are involved — how well the pharmacology is holding cravings and side effects. When something isn’t working, we adjust. That might mean a dose change, a therapy focus shift, or a step up or down in level of care. The plan follows the patient’s clinical picture, not the other way around.

Setbacks are treated as clinical data, not moral failure. If a relapse or symptom flare happens, the team’s job is to understand what led to it and refine the plan. Patients are not discharged for a relapse. Long-term recovery is often what happens after the acute treatment phase ends, and we plan for that from the first visit — through aftercare planning, coordinated hand-offs, and telehealth follow-up available across California.

Confidentiality and HIPAA Protections

Treatment records at Elevated Healing are protected under the Health Insurance Portability and Accountability Act (HIPAA) and, for substance use records specifically, under 42 CFR Part 2 — a federal regulation providing additional protection for substance use disorder treatment information. That means treatment status and clinical details are not disclosed to family members, employers, or third parties without your written authorization, except in narrowly defined legal circumstances (imminent harm, court order).

Practical protections include HIPAA-compliant scheduling and communication systems, secure insurance verification channels, and billing structured to minimize what appears on statements. Patients with heightened confidentiality concerns can request specific accommodations at intake — arrival timing, check-in flow, telehealth-first scheduling — and our admissions team will confirm what’s available.

Frequently Asked Questions

How is alcohol MAT different from opioid MAT?
The medications are different. Opioid MAT uses buprenorphine, naltrexone, or methadone. Alcohol MAT uses naltrexone (a different indication for the same molecule), acamprosate, or disulfiram. Both approaches combine medication with therapy — that’s the shared ‘MAT’ framework.
Do I have to be committed to total abstinence to start?
No. Naltrexone specifically supports reduction of heavy drinking days, so it’s a fit for patients whose initial goal is harm reduction rather than immediate full abstinence. Acamprosate and disulfiram require full abstinence to work. Goals can shift over time; medication can be adjusted accordingly.
What about Antabuse (disulfiram)?
Disulfiram works by producing an intensely unpleasant reaction if the patient drinks — nausea, flushing, headache. It’s a behavioral deterrent, not a craving reducer. It works for a specific patient profile — often someone with strong external motivation (job, family, legal) who wants a chemical safety net. It’s used selectively.
Are these medications addictive?
No. Naltrexone, acamprosate, and disulfiram are not addictive and have no recreational value. They don’t produce dependence.
How long will I be on medication for AUD?
There’s no fixed duration. Many patients benefit from at least 6–12 months. Some longer. Duration is a clinical decision based on your response, cravings, functional recovery, and goals — reviewed at each visit.
Does insurance cover alcohol MAT?
Most commercial insurance plans cover the medications and the psychiatric and therapy visits under mental health and substance use disorder benefits subject to federal parity requirements. Our admissions team verifies benefits within one business day. Reach us at (747) 888-3000.

If You’re in Crisis

If you or someone you love is in immediate crisis, help is available 24/7. You are not alone.

Trusted External Resources

Independent, evidence-based sources on the topics covered on this page:

SAMHSA — Medications for Alcohol Use Disorder →

SAMHSA’s overview of medications used for alcohol use disorder.

American Psychiatric Association — Addiction & Substance Use →

APA’s public-facing guidance on substance use disorders and treatment options.

National Institute on Alcohol Abuse and Alcoholism →

NIH institute researching alcohol use, treatment, and prevention.

FDA — Drug Information →

FDA drug approvals and safety communications.

SAMHSA National Helpline →

Free, confidential 24/7 referral service: 1-800-662-HELP.

Ready to Talk About Alcohol MAT?

Our admissions team can walk you through what treatment looks like, verify insurance benefits, and answer questions. Conversations are confidential.

Call us confidentially at (747) 888-3000 — or request a consultation online.

Schedule Your Consultation
Vital Voice Online

Schedule a Consultation

Fill out the form below and we'll get back to you within 24 hours.

Request Sent!

We've received your request and will be in touch within 24 hours.

Something went wrong